Amyloid β plaque-associated proteins C1q and SAP enhance the Aβ1–42 peptide-induced cytokine secretion by adult human microglia in vitro

Inflammation and Alzheimer’s disease

Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514 · see citing works

Staging of alzheimer's disease-related neurofibrillary changes

Braak, H., & Braak, E. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00021-6 · Cited by 2,357 · see citing works

Activation of microglial cells by β-amyloid protein and interferon-γ

Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314 · see citing works

In-vivo measurement of activated microglia in dementia

Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T., & Banati, R. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05625-2 · Cited by 1,054 · see citing works

Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease

Dickson, D. W., Lee, S. C., Mattiace, L. A., Yen, S.-H. C., & Brosnan, C. F. (1993) · Glia · doi:10.1002/glia.440070113 · Cited by 821 · see citing works

Complement activation by beta-amyloid in Alzheimer disease.

Rogers, J., Cooper, N. R., Webster, S., Schultz, J., McGeer, P. L., Styren, S. D., Civin, W. H., Brachova, L., Bradt, B., & Ward, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10016 · Cited by 817 · see citing works

The Pathogenesis of Senile Plaques

DICKSON, D. W. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199704000-00001 · Cited by 753 · see citing works

Glial‐Neuronal Interactions in Alzheimer's Disease: The Potential Role of a ‘Cytokine Cycle’ in Disease Progression

Griffin, W., Sheng, J. G., Royston, M., Gentleman, S., McKenzie, J., Graham, D. I., Roberts, G., & Mrak, R. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00136.x · Cited by 751 · see citing works

Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells.

Goldgaber, D., Harris, H. W., Hla, T., Maciag, T., DONNELLY, R. J., Jacobsen, J. S., Vitek, M. P., & Gajdusek, D. C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7606 · Cited by 591 · see citing works

Interleukin-1 Expression in Different Plaque Types in Alzheimerʼs Disease

Griffin, W. S. T., Sheng, J. G., Roberts, G. W., & Mrak, R. E. (1995) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199503000-00014 · Cited by 546 · see citing works

Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis

Pepys, M. B., Herbert, J., Hutchinson, W. L., Tennent, G. A., Lachmann, H. J., Gallimore, J. R., Lovat, L. B., Bartfai, T., Alanine, A., Hertel, C., et al. (2002) · Nature · doi:10.1038/417254a · Cited by 540 · see citing works

Structure of pentameric human serum amyloid P component

Emsley, J., White, H., O'Hara, B., Oliva, G., Srinivasan, N., Tickle, I., Blundell, T., Pepys, M., & Wood, S. (1994) · Nature · doi:10.1038/367338a0 · Cited by 488 · see citing works

Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro

Lue, L., Rydel, R. E., Brigham, E. F., Yang, L., Hampel, H. J., Murphy, G. M., Brachova, L., Yan, S., Walker, D. G., Shen, Y., et al. (2001) · Glia · doi:10.1002/glia.1072 · Cited by 382 · see citing works

<i>beta</i>-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain.

Jiang, H., Burdick, D., Glabe, C. G., Cotman, C. W., & Tenner, A. J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.10.5050 · Cited by 330 · see citing works

Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer’s disease

Matsuoka, Y., Picciano, M., Malester, B., LaFrancois, J., Zehr, C., Daeschner, J. M., Olschowka, J. A., Fonseca, M. I., O’Banion, M. K., Tenner, A. J., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64085-0 · Cited by 303 · see citing works

Translation of the Alzheimer Amyloid Precursor Protein mRNA Is Up-regulated by Interleukin-1 through 5′-Untranslated Region Sequences

Rogers, J. T., Leiter, L. M., McPhee, J., Cahill, C. M., Zhan, S.-S., Potter, H., & Nilsson, L. N. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6421 · Cited by 290 · see citing works

Purification and radiolabeling of human C1q.

Tenner, A. J., Lesavre, P., & Cooper, N. R. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.127.2.648 · Cited by 289 · see citing works

Complement activation in amyloid plaques in Alzheimer’s dementia

Eikelenboom, P., Hack, C. E., Rozemüller, A. J. M., & Stam, F. C. (1988) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02890024 · Cited by 288 · see citing works

Immunohistochemical and subcellular localization of parkin protein: Absence of protein in autosomal recessive juvenile parkinsonism patients

Shimura, H., Hattori, N., Kubo, S., Yoshikawa, M., Kitada, T., Matsumine, H., Asakawa, S., Minoshima, S., Yamamura, Y., Shimizu, N., et al. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199905)45:5 · Cited by 282 · see citing works

Costimulatory Effects of Interferon-γ and Interleukin-1β or Tumor Necrosis Factor α on the Synthesis of Aβ1-40 and Aβ1-42 by Human Astrocytes

Blasko, I., Veerhuis, R., Stampfer-Kountchev, M., Saurwein-Teissl, M., Eikelenboom, P., & Grubeck-Loebenstein, B. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0321 · Cited by 258 · see citing works

Complement-dependent Proinflammatory Properties of the Alzheimer's Disease β-Peptide

Bradt, B. M., Kolb, W. P., & Cooper, N. R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.3.431 · Cited by 255 · see citing works

Beta-protein amyloid is widely distributed in the central nervous system of patients with Alzheimer's disease.

Ogomori, K., Kitamoto, T., Tateishi, J., Sato, Y., Suetsugu, M., & Abe, M. (1989) · Europe PMC (PubMed Central) · Cited by 245 · see citing works

Localization and Cell Association of C1q in Alzheimer's Disease Brain

Afagh, A., Cummings, B. J., Cribbs, D. H., Cotman, C. W., & Tenner, A. J. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0043 · Cited by 224 · see citing works

The role of complement and activated microglia in the pathogenesis of Alzheimer's disease

Eikelenboom, P., & Veerhuis, R. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00108-x · Cited by 206 · see citing works

Subtypes and differential laminar distributions of ?A4 deposits in Alzheimer's disease: relationship with the intellectual status of 26 cases

Delaère, P., Duyckaerts, C. J., He, Y., Piette, F., & Hauw, J. (1991) · Acta Neuropathologica · doi:10.1007/bf00305876 · Cited by 173 · see citing works

Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q

Ying, S. C., Gewurz, A. T., Jiang, H., & Gewurz, H. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.1.169 · Cited by 167 · see citing works

Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with β-amyloid[25–35]

Meda, L., Baron, P., Prat, E., Scarpini, E. A., Scarlato, G., Cassatella, M. A., & Rossi, F. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00188-x · Cited by 154 · see citing works

Cytokines Associated with Amyloid Plaques in Alzheimer's Disease Brain Stimulate Human Glial and Neuronal Cell Cultures to Secrete Early Complement Proteins, But Not C1-Inhibitor

Veerhuis, R., Janssen, I., Groot, C. J. A. D., Muiswinkel, F. L. V., Hack, C. E., & Eikelenboom, P. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7199 · Cited by 154 · see citing works

Complement Component C1q Modulates the Phagocytosis of Aβ by Microglia

Webster, S. D., Yang, A. J., Margol, L., Garzon-Rodriguez, W., Glabe, C. G., & Tenner, A. J. (2000) · Experimental Neurology · doi:10.1006/exnr.1999.7260 · Cited by 138 · see citing works

Microglial activation in early stages of amyloid β protein deposition

Sasaki, A., Yamaguchi, H., Ogawa, A., Sugihara, S., & Nakazato, Y. (1997) · Acta Neuropathologica · doi:10.1007/s004010050713 · Cited by 132 · see citing works

Serum amyloid P component binds to histones and activates the classical complement pathway

Hicks, P. S., Saunero-Nava, L., Clos, T. W. D., & Mold, C. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.11.3689 · Cited by 130 · see citing works

β-Amyloid induces increased release of interleukin-1β from lipopolysaccharide-activated human monocytes

Lorton, D., Kocsis, J.-M., King, L., Madden, K., & Brunden, K. R. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(96)00030-6 · Cited by 108 · see citing works

The pentraxins: possible role in Alzheimer's disease and other innate inflammatory diseases.

Mcgeer, E., Yasojima, K., Schwab, C., & McGeer, P. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00288-3 · Cited by 86 · see citing works

Inhibition of Alzheimer β-Peptide Fibril Formation by Serum Amyloid P Component

Janciauskiene, S. M., de Frutos, P. G., Carlemalm, E., Dahlbäck, B., & Eriksson, S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.44.26041 · Cited by 82 · see citing works

Enhanced aggregation and β structure of amyloid β peptide after coincubation with C1Q

Webster, S. D., O’Barr, S. A., & Rogers, J. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490390412 · Cited by 81 · see citing works

Isolation and characterization of adult microglial cells and oligodendrocytes derived from postmortem human brain tissue

Groot, C. J. A. D., Montagne, L., Janssen, I., Ravid, R., van der Valk, P., & Veerhuis, R. (2000) · Brain Research Protocols · doi:10.1016/s1385-299x(99)00059-8 · Cited by 76 · see citing works

Distribution of beta amyloid associated proteins in plaques in Alzheimer's disease and in the non-demented elderly

Zhan, S., Veerhuis, R., Kamphorst, W., & Eikelenboom, P. (1995) · Neurodegeneration · doi:10.1016/1055-8330(95)90018-7 · Cited by 72 · see citing works

The C5a complement activation peptide increases IL-1β and IL-6 release from amyloid-β primed human monocytes: implications for Alzheimer’s disease

O’Barr, S. A., & Cooper, N. R. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00291-5 · Cited by 63 · see citing works

Complement regulators C1 inhibitor and CD59 do not significantly inhibit complement activation in Alzheimer disease

Yasojima, K., McGeer, E. G., & McGeer, P. L. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01514-0 · Cited by 58 · see citing works

Amyloid Precursor Protein (APP) in the Striatum in Alzheimerʼs Disease: An Immunohistochemical Study

Gearing, M., Wilson, R. W., Unger, E. R., Shelton, E. R., Chan, H. W., Masters, C. L., Beyreuther, K. T., & Mirra, S. S. (1993) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199301000-00004 · Cited by 40 · see citing works

Adult human microglia secrete cytokines when exposed to neurotoxic prion protein peptide: no intermediary role for prostaglandin E2

Veerhuis, R., Hoozemans, J. J. M., Janssen, I., Boshuizen, R. S., Langeveld, J., & Eikelenboom, P. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03273-5 · Cited by 37 · see citing works

Complement C1q Does Not Bind Monomeric β-Amyloid

Snyder, S. W., Wang, G. T., Barrett, L., Ladror, U. S., Casuto, D., Lee, C. M., Krafft, G. A., Holzman, R. B., & Holzman, T. F. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1121 · Cited by 34 · see citing works

Microglia in neurodegenerative disease

Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543 · see citing works

Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease

Guo, T., Zhang, D., Zeng, Y., Huang, T. Y., Xu, H., & Zhao, Y. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00391-7 · Cited by 994 · see citing works

Classification and basic pathology of Alzheimer disease

Duyckaerts, C., Delatour, B., & Potier, M.-C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0532-1 · Cited by 1,031 · see citing works

The role of the anaphylatoxins in health and disease

Klos, A., Tenner, A. J., Johswich, K.-O., Ager, R. R., Reis, E. S., & Köhl, J. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.04.027 · Cited by 730 · see citing works

Alzheimer's Disease: From Pathology to Therapeutic Approaches

Jakob‐Roetne, R., & Jacobsen, H. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200802808 · Cited by 626 · see citing works

Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer’s disease

Cai, Z., Hussain, M. D., & Yan, L.-J. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2013.833510 · Cited by 583 · see citing works

Inflammatory markers in AD and MCI patients with different biomarker profiles

Schuitemaker, A., Dik, M. G., Veerhuis, R., Scheltens, P., Schoonenboom, N. S. M., Hack, C. E., Blankenstein, M. A., & Jonker, C. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.01.014 · Cited by 149 · see citing works

Binding and uptake of Aβ1‐42 by primary human astrocytes <i>in vitro</i>

Nielsen, H. M., Veerhuis, R., Holmqvist, B., & Janciauskiene, S. (2009) · Glia · doi:10.1002/glia.20822 · Cited by 96 · see citing works

C1q is increased in cerebrospinal fluid‐derived extracellular vesicles in Alzheimer's disease: A multi‐cohort proteomics and immuno‐assay validation study

Chatterjee, M., Özdemir, S., Kunadt, M., Koel‐Simmelink, M., Boiten, W., Piepkorn, L., Pham, T. V., Chiasserini, D., Piersma, S. R., Knol, J. C., et al. (2023) · Alzheimer's &amp; Dementia · doi:10.1002/alz.13066 · Cited by 47 · see citing works

Evidence for three loci modifying age‐at‐onset of Alzheimer's disease in early‐onset <i>PSEN2</i> families

Marchani, E. E., Bird, T. D., Steinbart, E. J., Rosenthal, E., Yu, C., Schellenberg, G. D., & Wijsman, E. M. (2010) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31072 · Cited by 29 · see citing works

"Lipopolysaccharide-induced animal models for neuroinflammation – An overview."

Silva, A., Fiadeiro, M. B., Bernardino, L. I., Fonseca, C. P., Baltazar, G., & Cristóvão, A. C. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578273 · Cited by 76 · see citing works

Characterisation of ReNcells CX and VM stimulated with interleukin-1β and lipopolysaccharide

Cheung, K. A. K., Abeysinghe, P., Vaswani, K., et al. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105326 · Cited by 4 · see citing works

Role of Neuroinflammation in the Trajectory of Alzheimer’s Disease and in vivo Quantification Using PET

Edison, P., & Brooks, D. J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179929 · Cited by 62 · see citing works

Neuroinflammation and oxidative injury in developmental neurotoxicity

Milatović, D., Zaja‐Milatovic, S., BREYER, R. M., Aschner, M., & Montine, T. J. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-382032-7.10064-5 · Cited by 13 · see citing works

Alzheimer’s Disease Research Using Human Microglia

Lue, L., Beach, T. G., & Walker, D. G. (2019) · Cells · doi:10.3390/cells8080838 · Cited by 26 · see citing works